Shivshakti Drugs Private Limited
Manufacturer of sugar candy, refined sugar, pharmaceuticals, and health aids with indigenous and imported technology.
2000 | Medak, Telangana (India) | Active
Shivshakti Drugs Profile
Key Indicators
- Authorised Capital ₹ 8.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 24 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.40 Cr
- Revenue Growth -15.29%
- Profit Growth -79.73%
- Ebitda 202.18%
- Net Worth 7.08%
- Total Assets -16.03%
About Shivshakti Drugs
Shivshakti Drugs Private Limited (SDPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 June 2000 and has a history of 24 years and eight months. Its registered office is in Medak, Telangana, India.
The Corporate was formerly known as Shivshakti Drugs Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 5.00 M.
The company has closed loans amounting to ₹3.40 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Krishnadevi Agrawal and Pawankumar Agrawal serve as directors at the Company.
Company Details
- Location
Medak, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74110TG2000PTC034665
- Company No.
034665
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jun 2000
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Agriculture
Who are the key members and board of directors at Shivshakti Drugs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pawankumar Agrawal  | Director | 30-Jan-2006 | Current |
| Krishnadevi Agrawal | Director | 16-Jun-2015 | Current |
Financial Performance of Shivshakti Drugs.
Shivshakti Drugs Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 15.29% decrease. The company also saw a substantial fall in profitability, with a 79.73% decrease in profit. The company's net worth moved up by a moderate rise of 7.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shivshakti Drugs?
In 2019, Shivshakti Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vision Pharmacoat Private LimitedKrishnadevi Agrawal and Pawankumar Agrawal are mutual person
Vaikuntha Intermediates Private LimitedKrishnadevi Agrawal and Pawankumar Agrawal are mutual person
Charges (Loans)
Open Charges
₹0
Satisfied Charges
₹33.95 M
Charges Breakdown by Lending Institutions
- The A.P.Mahesh Co-Operative Urban Bank Limited : 1.50 Cr
- The A.P. Mahesh Co-Op Urban Bank Limited : 1.35 Cr
- Hdfc Bank Limited : 0.55 Cr
- A.P. State Financial Corporation : 0.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Dec 2016 | Hdfc Bank Limited | ₹5.00 M | Satisfied |
| 03 Feb 2014 | The A.P. Mahesh Co-Op Urban Bank Limited | ₹1.35 Cr | Satisfied |
| 02 Jun 2007 | Hdfc Bank Limited | ₹0.45 M | Satisfied |
| 14 Nov 2006 | The A.P.Mahesh Co-Operative Urban Bank Limited | ₹1.50 Cr | Satisfied |
| 18 Jan 2003 | A.P. State Financial Corporation | ₹0.00 | Satisfied |
How Many Employees Work at Shivshakti Drugs?
Unlock and access historical data on people associated with Shivshakti Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shivshakti Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shivshakti Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
